HNF-4alpha Negatively Regulates Hepcidin Expression Through BMPR1A in HepG2 Cells

Biological Trace Element Research

Volumn 176, Issue 2, 2017, Pages 294-304

  Shi, Wencai ^a,b   Wang, Heyang ^a   Zheng, Xuan ^b   Jiang, Xin ^a   Xu, Zheng ^a   Shen, Hui ^a   Li, Min ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

BMPR1A; HNF 4 hepcidin; pSMAD1 5 8

Indexed keywords

ACTIN RELATED PROTEIN 2; ACTIN RELATED PROTEIN 2A; ACTIN RELATED PROTEIN 2B; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; HEMOJUVELIN; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HEPCIDIN; INTERLEUKIN 6; MESSENGER RNA; SMAD1 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; UNCLASSIFIED DRUG; BMPR1A PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; HEP-G2 CELL LINE; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DOWN REGULATION; GENETICS; METABOLISM; TUMOR CELL CULTURE;

BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; DOWN-REGULATION; HEP G2 CELLS; HEPATOCYTE NUCLEAR FACTOR 4; HEPCIDINS; HUMANS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84988700983     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-016-0846-5     Document Type: Article

References (45)

1. Fleming MD (2008) The regulation of hepcidin and its effects on systemic and cellular iron metabolism. Hematology Am Soc Hematol Educ Program:151–158
2. Sikorska K, Stalke P, Romanowski T, Rzepko R, Bielawski KP (2013) Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C. Hepatobiliary Pancreat Dis Int 12:377–384
3. Nelson JE, Klintworth H, Kowdley KV (2012) Iron metabolism in nonalcoholic fatty liver disease. Curr Gastroenterol Rep 14:8–16
4. Datz C, Felder TK, Niederseer D, Aigner E (2013) Iron homeostasis in the metabolic syndrome. Eur J Clin Investig 43:215–224
5. O'Brien J, Powell LW (2012) Non-alcoholic fatty liver disease: is iron relevant? Hepatol Int 6:332–341
6. Valenti L, Rametta R, Dongiovanni P, Motta BM, Canavesi E, Pelusi S, Pulixi EA, Fracanzani AL, Fargion S (2012) The A736 V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease. PLoS One 7:e48804
7. Dongiovanni P, Fracanzani AL, Fargion S, Valenti L (2011) Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. J Hepatol 55:920–932
8. Aigner E, Theurl I, Theurl M, Lederer D, Haufe H, Dietze O, Strasser M, Datz C, Weiss G (2008) Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. Am J Clin Nutr 87:1374–1383
9. Tsuchiya H, Ebata Y, Sakabe T, Hama S, Kogure K, Shiota G (2013) High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice. Metabolism 62:62–69
10. Ravasi G, Pelucchi S, Trombini P, Mariani R, Tomosugi N, Modignani GL, Pozzi M, Nemeth E, Ganz T, Hayashi H, Barisani D, Piperno A (2012) Hepcidin expression in iron overload diseases is variably modulated by circulating factors. PLoS One 7:e36425
11. Mitsuyoshi H, Yasui K, Harano Y, Endo M, Tsuji K, Minami M, Itoh Y, Okanoue T, Yoshikawa T (2009) Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease. Hepatol Res 39:366–373
12. Barisani D, Pelucchi S, Mariani R, Galimberti S, Trombini P, Fumagalli D, Meneveri R, Nemeth E, Ganz T, Piperno A (2008) Hepcidin and iron-related gene expression in subjects with Dysmetabolic hepatic iron overload. J Hepatol 49:123–133
13. Sam AH, Busbridge M, Amin A, Webber L, White D, Franks S, Martin NM, Sleeth M, Ismail NA, Mat Daud N, Papamargaritis D, Le Roux CW, Chapman RS, Frost G, Bloom SR, Murphy KG (2013) Hepcidin levels in diabetes mellitus and polycystic ovary syndrome. Diabetic MED 30:1495–1499
14. Fernández-Real JM, Equitani F, Moreno JM, Manco M, Ortega F, Ricart W (2009) Study of circulating prohepcidin in association with insulin sensitivity and changing iron stores. J Clin Endocrinol Metab 94:982–988
15. Carvalhana S, Machado MV, Cortez-Pinto H (2012) Improving dietary patterns in patients with nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 15:468–473
16. Gentile CL, Frye MA, Pagliassotti MJ (2011) Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease. Biofactors 37:8–16
17. Gentile CL, Pagliassotti MJ (2008) The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. J Nutr Biochem 19:567–576
18. Hertz R, Kalderon B, Byk T, Berman I, Za'tara G, Mayer R, Bar-Tana J (2005) Thioesterase activity and acyl-CoA/fatty acid cross-talk of hepatocyte nuclear factor-4alpha. J Biol Chem 280:24451–24461
19. Pégorier JP, Le May C, Girard J (2004) Control of gene expression by fatty acids. J Nutr 134:2444S–2449S
20. Jazurek M, Dobrzyń P, Dobrzyń A (2008) Regulation of gene expression by long-chain fatty acids. Postepy Biochem 54:242–250
21. De Souza CT, Frederico MJ, da Luz G, Cintra DE, Ropelle ER, Pauli JR, Velloso LA (2010) Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4α pathway in insulin resistant mice. J Physiol 588:2239–2253
22. Souza Pauli LS, Ropelle EC, de Souza CT, Cintra DE, da Silva AS, de Almeida Rodrigues B, de Moura LP, Marinho R, de Oliveira V, Katashima CK, Pauli JR, Ropelle ER (2014) Exercise training decreases mitogen-activated protein kinase phosphatase-3 expression and suppresses hepatic gluconeogenesis in obese mice. J Physiol 592:1325–1340
23. Courselaud B, Pigeon C, Inoue Y, Inoue J, Gonzalez FJ, Leroyer P, Gilot D, Boudjema K, Guguen-Guillouzo C, Brissot P, Loréal O, Ilyin G (2002) C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J Biol Chem 277:41163–41170
24. Diedra M, Nancy C (2006) Interleukin-6 induces hepcidin expression through STAT3. Blood 108:3204–3209
25. Ling C, Wang Y, Zhang Y, Ejjigani A, Yin Z, Lu Y, Wang L, Wang M, Li J, Hu Z, Aslanidi GV, Zhong L, Gao G, Srivastava A, Ling C (2014) Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model. Hum Gene Ther 25:1023–1034
26. Wang LN, Wang Y, Lu Y, Yin ZF, Zhang YH, Aslanidi GV, Srivastava A, Ling CQ, Ling C (2014) Pristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo. J Intern Med 12:20–34
27. Dijke P, Korchynskyi O, Valdimarsdottir G, Goumans MJ (2003) Controlling cell fate by bone morphogenetic protein receptors. Mol Cel Endo 211:105–113
28. Watt AJ, Garrison WD, Duncan SA (2003) A central regulator of hepatocyte differentiation and function. Hepatology 37:1249–1253
29. Hirota K, Sakamaki J, Ishida J, Shimamoto Y, Nishihara S, Kodama N, Ohta K, Yamamoto M, Tanimoto K, Fukamizu A (2008) A combination of HNF-4 and Foxo1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding. J Biol Chem 283:32432–32441
30. Sladek FM (1993) Orphan receptor HNF-4 and liver-specific gene expression. Receptor 3:223–232
31. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR (2002) Requirement of Bmpr1a for Müllerian duct regression during male sexual development. Nat Genet 32:408–410
32. Gaussin V, Van de Putte T, Mishina Y, Hanks MC, Zwijsen A, Huylebroeck D, Behringer RR, Schneider MD (2002) Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK-3. Proc Natl Acad Sci U S A 99:2878–2883
33. Howe JR, Bair JL, Sayed MG, Anderson ME, Mitros FA, Petersen GM, Velculescu VE, Traverso G, Vogelstein B (2001) Germline mutations of the gene encoding bone morphogenetic protein receptor 1 A in juvenile polyposis. Nat Genet 28:184–187
34. Yi SE, LaPolt PS, Yoon BS, Chen JY, Lu JK, Lyons KM (2001) The type I BMP receptor BmprIB is essential for female reproductive function. Proc Natl Acad Sci U S A 98:7994–7999
35. Sahni V, Mukhopadhyay A, Tysseling V, Hebert A, Birch D, Mcguire TL, Stupp SI, Kessler JA (2010) BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury. J Neur 30:1839–1855
36. Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, Yamashita H, Enomoto S, Miyazono K (1996) Identification of types I and II serine/threonine kinase receptors for growth/differentiation factor-5. J Biol Chem 271:21345–21352
37. Macias-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL (1998) Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK-2. J Biol Chem 273:25628–25636
38. Calva-Cerqueira D, Dahdaleh FS, Woodfield G, Chinnathambi S, Nagy PL, Larsen-Haidle J, Weigel RJ, Howe JR (2010) Discovery of the BMPR1A promoter and germline mutations that cause juvenile polyposis. Hum Mol Genet 19:4654–4662
39. Dahdaleh FS, Carr JC, Calva D, Howe JR, Howe JR (2011) SP1 regulates the transcription of BMPR1A. J Surg Res 171:e15–e20
40. Talianidis I, Tambakaki A, Toursounova J, Zannis VI (1995) Complex interactions between SP1 bound to multiple distal regulatory sites and HNF-4 bound to the proximal promoter lead to transcriptional activation of liver-specific human APOCIII gene. Biochemistry 34:10298–10309
41. Kardassis D, Falvey E, Tsantili P, Hadzopoulou-Cladaras M, Zannis V (2002) Direct physical interactions between HNF-4 and Sp1 mediate synergistic transactivation of the apolipoprotein CIII promoter. Biochemistry 41:1217–1228
42. Hung HL, High KA (1996) Liver-enriched transcription factor HNF-4 and ubiquitous factor NF-Y are critical for expression of blood coagulation factor X. J Biol Chem 271:2323–2331
43. Li ZY, Xi Y, Zhu WN, Zeng C, Zhang ZQ, Guo ZC, Hao DL, Liu G, Feng L, Chen HZ, Chen F, Lv X, Liu DP, Liang CC (2011) Positive regulation of hepatic miR-122 expression by HNF4α. J Hepatol 55:602–611
44. Castoldi M, Vujic Spasic M, Altamura S, Elmén J, Lindow M, Kiss J, Stolte J, Sparla R, D'Alessandro LA, Klingmüller U, Fleming RE, Longerich T, Gröne HJ, Benes V, Kauppinen S, Hentze MW, Muckenthaler MU (2011) The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J Clin Invest 121:1386–1396
45. Matak P, Chaston TB, Chung B, Srai SK, McKie AT, Sharp PA (2009) Activated macrophages induce hepcidin expression in HuH7 hepatoma cells. Haematologica 94:773–780